F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Oxidative damage has been reported in Rett syndrome (RTT), a pervasive developmental disorder caused in up to 95% of cases by mutations in the X-linked methyl-CpG binding protein 2 gene. Herein, we have synthesized F(2)-dihomo-isoprostanes (F(2)-dihomo-IsoPs), peroxidation products from adrenic acid (22:4 n-6), a known component of myelin, and tested the potential value of F(2)-dihomo-IsoPs as a novel disease marker and its relationship with clinical presentation and disease progression. F(2)-dihomo-IsoPs were determined by gas chromatography/negative-ion chemical ionization tandem mass spectrometry. Newly synthesized F(2)-dihomo-IsoP isomers [ent-7(RS)-F(2t)-dihomo-IsoP and 17-F(2t)-dihomo-IsoP] were used as reference standards. The measured ions were the product ions at m/z 327 derived from the [M-181](-) precursor ions (m/z 597) produced from both the derivatized ent-7(RS)-F(2t)-dihomo-IsoP and 17-F(2t)-dihomo-IsoP. Average plasma F(2)-dihomo-IsoP levels in RTT were about one order of magnitude higher than those in healthy controls, being higher in typical RTT as compared with RTT variants, with a remarkable increase of about two orders of magnitude in patients at the earliest stage of the disease followed by a steady decrease during the natural clinical progression. hese data indicate for the first time that quantification of F(2)-dihomo-IsoPs in plasma represents an early marker of the disease and may provide a better understanding of the pathogenic mechanisms behind the neurological regression in patients with RTT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990 · cited 1×
“) is involved in the pathogenesis of Rett syndrome (RTT) (1), a severe”
BackgroundReversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230
Kinney, H. C., Ann brody, B., Kloman, A. S., & Gilles, F. H. (1988) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198805000-00003 · Cited by 888
MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511
Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome
Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., Zoghbi, H., Percy, A., & Glaze, D. G. (2008) · Neurology · doi:10.1212/01.wnl.0000291011.54508.aa · Cited by 498 · cited 2×
“6 RTT clinical severity was assessed using the clinical severity score (CSS), a validated clinical rating specifically designed for RTT (25), based on 13 individual, ordinal categories measuring clinical”
MethodMapping Infant Brain Myelination with Magnetic Resonance Imaging
Deoni, S. C. L., Mercure, E., Blasi, A., Gasston, D., Thomson, A., Johnson, M., Williams, S. C. R., & Murphy, D. G. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2106-10.2011 · Cited by 497 · cited 1×
“, quantitative myelin imaging with mcDESPOT) (39) showing that, at the mean age of”
BackgroundClinical manifestations and stages of rett syndrome
Hagberg, B. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10020 · Cited by 416
Selective dendritic alterations in the cortex of Rett syndrome
Armstrong, D., Dunn, J. K., Antalffy, B., & Trivedi, R. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199503000-00006 · Cited by 378
Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome
Kriaucionis, S., Paterson, A., Curtis, J., Guy, J., MacLeod, N., & Bird, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01665-05 · Cited by 219
Systemic oxidative stress in classic Rett syndrome
De Felice, C., Ciccoli, L., Leoncini, S., Signorini, C., Rossi, M., Vannuccini, L., Guazzi, G., Latini, G., Comporti, M., Valacchi, G., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.016 · Cited by 148 · cited 3×
“In addition, our findings indicate the importance of plasma as a suitable biological fluid for detecting markers of central nervous system oxidative damage in RTT (16, 55, 56) and underline the key role of interaction between organic chemists, O.”
BackgroundSelf-citation
Cited by
The isoprostanes—25 years later
Milne, G. L., Dai, Q., & Roberts, L. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.007 · Cited by 335
Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome
De Felice, C., Della Ragione, F., Signorini, C., Leoncini, S., Pecorelli, A., Ciccoli, L., Scalabrì, F., Marracino, F., Madonna, M., Belmonte, G., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.006 · Cited by 126
Self-citationPacheco, N. L., Heaven, M. R., Holt, L. M., Crossman, D. K., Boggio, K. J., Shaffer, S. A., Flint, D. L., & Olsen, M. L. (2017) · Molecular Autism · doi:10.1186/s13229-017-0174-4 · Cited by 90
Gold, W. A., Williamson, S. L., Kaur, S., Hargreaves, I. P., Land, J. M., Pelka, G. J., Tam, P. P. L., & Christodoulou, J. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.02.012 · Cited by 73
Leoncini, S., De Felice, C., Signorini, C., Zollo, G., Cortelazzo, A., Durand, T., Galano, J.-M., Guerranti, R., Rossi, M., Ciccoli, L., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/421624 · Cited by 71
“Likewise, when compared to our control group, levels of the anti-inflammatory cytokine IL-37 [49] were found to be significantly elevated inMECP2RTT as the consequence of a compensatory mechanism.”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- De Felice, C., Signorini, C., Durand, T., Oger, C., Guy, A., Bultel-Poncé, V., Galano, J.-M., Ciccoli, L., Leoncini, S., D'Esposito, M., Filosa, S., Pecorelli, A., Valacchi, G., & Hayek, J.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 52
- Issue
- 12
- Pages
- 2287-2297
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W1964156857
- Cited by
- 91
- References
- 14
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome. https://app.cochat.ai/papers/10.1194/jlr.p017798
- The paper
- De Felice, C., Signorini, C., Durand, T., Oger, C., Guy, A., Bultel-Poncé, V., Galano, J.-M., Ciccoli, L., Leoncini, S., D'Esposito, M., Filosa, S., Pecorelli, A., Valacchi, G., & Hayek, J. (2011). F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome. Journal of Lipid Research. https://doi.org/10.1194/jlr.p017798
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.